affitope ad02
Vaccineexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2008 (NCT00633841)
Timeline
Indications
Studied for
Mechanism of action
- Amyloid beta A4 proteinImmunity, active
APP immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- affitope ad02
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02008513 | Phase 2 | Jun 1, 2013 | Affiris AG, Sorbonne University |
| NCT01117818 | Phase 2 | Sep 1, 2010 | Affiris AG, Sorbonne University |
| NCT01093664 | Phase 1 | Oct 1, 2009 | Affiris AG |
| NCT00633841 | Phase 1 | Feb 1, 2008 | Affiris AG |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Affiris AG | For profit | 4 | 4 | 2 | 2008 |
| Sorbonne University | Academic/Hospital | 2 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1